-
Mashup Score: 90
A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults With Long COVID. – Full Text View.
Source: clinicaltrials.govCategories: Cardiologists, Latest HeadlinesTweet
A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults With Long COVID. – Full Text View.
Introducing the @Yale #PaxLCTrial, a research study that is digital, decentralized, and participant-centric; testing whether Paxlovid can improve health for patients living with #LongCovid. @YaleMed @YaleCII #YaleCORE @PutrinoLab @WesElyMD @VirusesImmunity https://t.co/arFocSsWIV https://t.co/pfLGpfdb25